LJPC

La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News

By David Moadel, InvestorPlace Contributor
A headline-grabbing takeover deal could be impactful for the medical community - and today, it's definitely huge news for LJPC stock holders.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer
It's time to dive into another day of investing and we're starting it off with a look at the biggest pre-market stock movers for Thursday.

2 Stable and 2 Speculative Biotech Stocks to Buy

By Josh Enomoto, InvestorPlace Contributor
Biotech stocks are incredibly wild affairs, but if you have an iron stomach, these four companies could potentially offer serious upside.

La Jolla Pharmaceutical Company (LJPC) Stock Skyrockets on Hypotension Study Results

By William White, InvestorPlace Writer
La Jolla Pharmaceutical Company (LJPC) stock was skyrocketing on Monday following positive results from its hypotension study.